Development of rabbit monoclonal antibodies for detection of alpha-dystroglycan in normal and dystrophic tissue

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Fortunato, Marisa J ^a   Ball, Charlotte E ^a   Hollinger, Katrin ^b   Patel, Niraj B ^a   Modi, Jill N ^a   Rajasekaran, Vedika ^a   Nonneman, Dan J ^c   Ross, Jason W ^b   Kennedy, Eileen J ^a   Selsby, Joshua T ^b   Beedle, Aaron M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c U S MEAT ANIMAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; DYSTROPHIN; FUKUTIN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; RABBIT ANTISERUM; DAG1 PROTEIN, HUMAN; DYSTROGLYCAN; PRIMER DNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BECKER MUSCULAR DYSTROPHY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DYSTROGLYCANOPATHY; GLYCOSYLATION; IMMUNOFLUORESCENCE; MALE; MOLECULAR WEIGHT; MOUSE; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SWINE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HYBRIDOMA; IMAGE PROCESSING; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; PIG; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CLONING, MOLECULAR; DNA PRIMERS; DYSTROGLYCANS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION; HYBRIDOMAS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE ANALYSIS, DNA; SWINE;

EID: 84901253912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097567     Document Type: Article

References (31)

1. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP (1991) Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112: 135-148. (Pubitemid 21909606)
2. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, et al. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702.
3. Holt KH, Crosbie RH, Venzke DP, Campbell KP (2000) Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett 468: 79-83. (Pubitemid 30101686)
4. Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-823. (Pubitemid 23241091)
5. Yang B, Jung D, Motto D, Meyer J, Koretzky G, et al. (1995) SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 270: 11711-11714.
6. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, et al. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 6: 831-841. (Pubitemid 27239066)
7. Ervasti JM, Campbell KP (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66: 1121-1131. (Pubitemid 121001402)
8. Brancaccio A, Schulthess T, Gesemann M, Engel J (1995) Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan. FEBS Lett 368: 139-142.
9. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, et al. (2010) O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327: 88-92.
10. Matsumara K, Tome FM, Collin H, Leturcq F, Jeanpierre M, et al. (1994) Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy. Neuromuscul Disord 4: 115-120. (Pubitemid 24124592)
11. Di Blasi C, Morandi L, Barresi R, Blasevich F, Cornelio F, et al. (1996) Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers. Acta Neuropathol 92: 369-377. (Pubitemid 26317104)
12. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltran-Valero de Bernabe D, et al. (2011) A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 364: 939-946.
13. Geis T, Marquard K, Rodl T, Reihle C, Schirmer S, et al. (2013) Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy. Neurogenetics 14: 205-213.
14. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. (2002) Posttranslational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418: 417-422. (Pubitemid 34826841)
15. Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Nonaka I, et al. (2001) Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57: 115-121. (Pubitemid 32634859)
16. Kano H, Kobayashi K, Herrmann R, Tachikawa M, Manya H, et al. (2002) Deficiency of α-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 291: 1283-1286.
17. Jiménez-Mallebrera C, Torelli S, Brown SC, Feng L, Brockington M, et al. (2003) Profound skeletal muscle depletion of α-dystroglycan in Walker-Warburg syndrome. Eur J Paediatr Neurol 7: 129-137. (Pubitemid 36700751)
18. Live D, Wells L, Boons GJ (2013) Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy. Chembiochem 14: 2392-2402.
19. Esser AK, Miller MR, Huang Q, Meier MM, Beltrán-Valero De Bernabé D, et al. (2013) Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer. J Biol Chem 288: 2132-2142.
20. Akhavan A, Griffith OL, Soroceanu L, Leonoudakis D, Luciani-Torres MG, et al. (2012) Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes. Cancer Res 72: 2578-2588.
21. Martin LT, Glass M, Dosunmu E, Martin PT (2007) Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors. Hum Pathol 38: 1657-1668. (Pubitemid 47589088)
22. Beedle AM, Turner AJ, Saito Y, Lueck JD, Foltz SJ, et al. (2012) Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. J Clin Invest 122: 3330-3342.
23. McGlone J, Swanson J, Ford S, Underwood W, Mitloehner F, et al. (2010) Guide for Care and Use of Agricultural Animals in Agricultural Research and Teaching. 3rd edition. Savoy: Fed. Animal Science Society. 177 p.
24. Nonneman DJ, Brown-Brandl T, Jones SA, Wiedmann RT, Rohrer GA (2012) A defect in dystrophin causes a novel porcine stress syndrome. BMC Genomics 13: 233.
25. Hollinger K, Yang CX, Montz RE, Nonneman D, Ross JW, et al. (2014) Dystrophin insufficiency causes selective muscle histopathology and loss of dystrophin-glycoprotein complex assembly in pig skeletal muscle. FASEB J, 28: 1600-1609.
26. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MBA (2001) Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan. J Cell Biol 155: 301-310. (Pubitemid 34289305)
27. Beedle AM, Hamid J, Zamponi GW (2002) Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations. J Membr Biol 187: 225-238. (Pubitemid 34587778)
28. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepnick K, et al. (1993) Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 2: 1651-1657. (Pubitemid 23358684)
29. Hermann R, Straub V, Blank M, Kutzick C, Franke N, et al. (2000) Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 9: 2335-2340.
30. Pavoni E, Sciandra F, Barca S, Giardina B, Petrucci TC, et al. (2005) Immunodetection of partially glycosylated isoforms of α-dystroglycan by a new monoclonal antibody against its β-dystroglycan-binding epitope. FEBS Lett 579: 493-499. (Pubitemid 40092433)
31. Singh J, Itahana Y, Knight-Krajewski S, Kanagawa M, Campbell KP, et al. (2004) Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res 64: 6152-6159. (Pubitemid 39129416)